appScorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
News & Opinions
Medi-Caps Standalone December 2023 Net Sales at Rs 3.05 crore, up 23895.28% Y-o-Y
9 months ago•Moneycontrol
Medi Caps reports standalone net loss of Rs 0.14 crore in the December 2022 quarter
1 year ago•Business Standard
Medi-Caps secures RERA nod on Medicaps Business Park project
2 years ago•Business Standard
Medi Caps gets approval under RERA for Real Estate Project ‘Medicaps Business Park’
2 years ago•India Infoline
Medi Caps consolidated net profit rises 3.91% in the September 2021 quarter
3 years ago•Business Standard
Medi Caps consolidated net profit rises 58.77% in the June 2021 quarter
3 years ago•Business Standard
Medi Caps reports standalone net loss of Rs 0.05 crore in the June 2021 quarter
3 years ago•Business Standard